# Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes

Study · id `cardio:ct-nct05431296` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05431296](<https://clinicaltrials.gov/study/NCT05431296>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05431296

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Coronary and vascular disease; Diabetes and metabolic disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.

## Technical summary

Registry record NCT05431296. Randomized; no masking; primary purpose treatment. Start 2023-02-07 (actual); primary completion 2024-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT05431296, source copy `cardio:ctgov-nct05431296-2024-07-03`, retrieved 2026-10-26)
- Started: 2023-02-07 (actual) (ClinicalTrials.gov record NCT05431296, source copy `cardio:ctgov-nct05431296-2024-07-03`, retrieved 2026-10-26)
- Primary completion: 2024-08 (anticipated) (ClinicalTrials.gov record NCT05431296, source copy `cardio:ctgov-nct05431296-2024-07-03`, retrieved 2026-10-26)
- Completion: 2025-02 (anticipated) (ClinicalTrials.gov record NCT05431296, source copy `cardio:ctgov-nct05431296-2024-07-03`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05431296, source copy `cardio:ctgov-nct05431296-2024-07-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05431296-2024-07-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
- Acronym: GLAM
- Condition: Type 2 Diabetes
- Condition: Acute Myocardial Infarction
- Condition: Acute Myocardial Infarction With ST Elevation
- Condition: Diabetes Complications
- Intervention (Device): Dexcom ONE Continuous Glucose Monitoring System
- Lead sponsor: Imperial College London
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Imperial College London (`cardio:org-imperial-college-london`)

## Provenance

Content hash: c0b02dd932f1a477e4f40768a562703f2b08e6766a02f8518754a2aaecfc2a6e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
